September 15, 2023
WASHINGTON (Reuters) – The U.S. Federal Trade Commission on Thursday warned brand-name drugmakers they could face legal action if they improperly list patents with federal health […]
August 18, 2023
(Reuters) – Blue Shield of California plans to stop using most of CVS Health’s pharmacy benefit management services and work with others, including Amazon.com and Mark […]
July 5, 2023
Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients, with the tussle over profits now spilling into statehouses across […]
June 22, 2023
BRUSSELS (Reuters) – Europe’s pharmaceutical sector could lose out to increased competition from emerging markets, China and the U.S. in terms of research and innovation if […]
June 22, 2023
NEW YORK (Reuters) – The Pharmaceutical Research and Manufacturers of America (PhRMA), the leading industry lobby group, and two other organizations on Wednesday said they were […]
June 20, 2023
Noses are like caverns — twisting, turning, no two exactly the same. But if you nose past anyone’s nostrils, you’ll discover a surprisingly sprawling space. “The […]
April 7, 2023
A new federal rule seeks to reduce Medicare Advantage insurance plans’ prior authorization burdens on physicians while also ensuring that enrollees have the same access to […]
February 21, 2023
WASHINGTON (Reuters) – The U.S. government will select the 10 costliest prescription medicines to Medicare for negotiating prices with drugmakers starting early next year, the program’s […]
February 13, 2023
NEW YORK (Reuters) – Martin Shkreli on Friday urged a U.S. judge not to hold him in civil contempt for failing to provide federal and state […]